12
Participants
Start Date
April 11, 2019
Primary Completion Date
April 11, 2019
Study Completion Date
July 22, 2019
exposition half-face
Patients will be included in the study and exposed on a half-face from Day1 to Day5. The other half-face will serve as unexposed control. The effect of blue light on the melasma lesions will be assessed from Day 1 to Day 6 using chromametry and a modified Melasma Area and Severity Index on standardized photographs
Centre de Pharmacologie Clinique Appliquée à la Dermatologie, Nice
Centre Hospitalier Universitaire de Nice
OTHER